Prednisolone Sodium Phosphate Ophthalmic Solution 1%

DRUG2 trials

Sponsors

ORA, Inc.

Conditions

Allergic ConjunctivitisChronic Allergic Conjunctivitis

Phase 4

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

CompletedNCT01534195

ORA, Inc.Allergic Conjunctivitis

Start: 2012-01-31End: 2012-02-29Updated: 2019-03-26

Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model

CompletedNCT01730872

ORA, Inc.Chronic Allergic Conjunctivitis

Start: 2012-11-30End: 2012-12-31Updated: 2019-06-19